Dror Ortho-design, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
OTC.Pink
Dror Ortho-Design, Inc. has filed an amended definitive proxy statement, rescheduling its Special Meeting to June 23, 2025, to seek stockholder approval for a reverse stock split aimed at increasing its share price and facilitating a potential uplisting to NYSE American.
OTC.Pink
Dror Ortho-Design is asking stockholders to approve a reverse stock split at its special meeting on June 13, 2025, to increase its stock price and potentially uplist to the NYSE American.